@article{23677,
  keywords = {Antitubercular Agents, Aza Compounds, DNA Cleavage, DNA gyrase, Fluoroquinolones, Gatifloxacin, Microbial Sensitivity Tests, Moxifloxacin, Mutation, Mycobacterium leprae, Mycobacterium tuberculosis, Quinolines, Structure-Activity Relationship, Topoisomerase II Inhibitors},
  author = {Gomez C and Ponien P and Serradji N and Lamouri A and Pantel A and Capton E and Jarlier V and Anquetin G and Aubry A},
  title = {Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis.},
  abstract = {<p>Novel 3'-piperazinyl derivatives of the 8-hydrogeno and 8-methoxy-6-fluoro-1-cyclopropyl-4-quinolone-3-carboxylic acid scaffolds were designed, synthesized and characterized by (1)H, (13)C and (19)F NMR, and HRMS. The activity of these derivatives against pathogenic mycobacteria (M. leprae and M. tuberculosis), wild-type (WT) strains or strains harboring mutations implicated in quinolone resistance, were determined by measuring drug concentrations inhibiting cell growth (MIC) and/or DNA supercoiling by DNA gyrase (IC(50)), or inducing 25% DNA cleavage by DNA gyrase (CC(25)). Compound 4 (with a methoxy in R(8) and a secondary carbamate in R(3)') and compound 5 (with a hydrogen in R(8) and an ethyl ester in R(3)') displayed biological activities close to those of ofloxacin but inferior to those of gatifloxacin and moxifloxacin against M. tuberculosis and M. leprae WT DNA gyrases, whereas all of the compounds were less active in inhibiting M. tuberculosis growth and M. leprae mutant DNA gyrases. Since R(3)' substitutions have been poorly investigated previously, our results may help to design new quinolone derivatives in the future.</p>},
  year = {2013},
  journal = {Bioorganic & medicinal chemistry},
  volume = {21},
  pages = {948-56},
  month = {2013 Feb 15},
  issn = {1464-3391},
  doi = {10.1016/j.bmc.2012.12.011},
  note = {<p>pii: S0968-0896(12)00972</p>
},
  language = {eng},
}